Preterm infants, born before 37 weeks of gestation, are at a higher risk for complications such as respiratory distress, ...

Objectives: Complications found during surfactant therapy in Pressure-Support-Ventilation and Volume- Guarantee (PSV/VG) from Dräger-Babylog-8000. Patients and Methods: Descriptive and ...

In extremely preterm infants receiving surfactant, early intratracheal budesonide ... "a large pragmatic trial to assess the ...

Research led by the Royal Women's Hospital, Australia, has found that early intratracheal administration of budesonide mixed ...

Oxford, UK-based rare respiratory diseases focused AlveoGene today revealed it has been granted a Rare Pediatric Disease ...